Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1

Cancer Letters

Volumn 291, Issue 2, 2010, Pages 150-157

  Fukaya, Raita ^a   Ohta, Shigeki ^a   Yamaguchi, Masayuki ^b   Fujii, Hirofumi ^b   Kawakami, Yutaka ^a   Kawase, Takeshi ^a   Toda, Masahiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Brain cancer stem cell; Glioblastoma; Side population

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; NESTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN TUMOR; CANCER CELL CULTURE; CANCER STEM LIKE CELL; CARCINOGENICITY; CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL RENEWAL; CELL SUBPOPULATION; CONTROLLED STUDY; CULTURE MEDIUM; FLOW CYTOMETRY; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; MOUSE; NERVE CELL; NONHUMAN; NONOBESE DIABETIC MOUSE; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; SIDE POPULATION;

BRAIN NEOPLASMS; CELL CULTURE TECHNIQUES; CELL DIVISION; CELL LINE, TUMOR; CELL SEPARATION; CELL SHAPE; CULTURE MEDIA; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KINETICS; NEOPLASTIC STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA, NEOPLASM;

MUS;

EID: 77950021915     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.10.010     Document Type: Article

References (50)

1. Holland E.C. Gliomagenesis: genetic alterations and mouse models. Nat. Rev. Genet. 2 (2001) 120-129
2. Kleihues P., Louis D.N., Scheithauer B.W., Rorke L.B., Reifenberger G., Burger P.C., and Cavenee W.K. The WHO classification of tumors of the nervous system. J. Neuropathol. Exp. Neurol. 61 (2002) 215-225 (discussion 226-219)
3. Maher E.A., Furnari F.B., Bachoo R.M., Rowitch D.H., Louis D.N., Cavenee W.K., and DePinho R.A. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 15 (2001) 1311-1333
4. Sanai N., Alvarez-Buylla A., and Berger M.S. Neural stem cells and the origin of gliomas. New Engl. J. Med. 353 (2005) 811-822
5. Zhu Y., and Parada L.F. The molecular and genetic basis of neurological tumours. Nat. Rev. Cancer. 2 (2002) 616-626
6. Hirschmann-Jax C., Foster A.E., Wulf G.G., Nuchtern J.G., Jax T.W., Gobel U., Goodell M.A., and Brenner M.K. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. USA 101 (2004) 14228-14233
7. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., and Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63 (2003) 5821-5828
8. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., and Dirks P.B. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
9. Hemmati H.D., Nakano I., Lazareff J.A., Masterman-Smith M., Geschwind D.H., Bronner-Fraser M., and Kornblum H.I. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. USA 100 (2003) 15178-15183
10. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., Fiocco R., Foroni C., Dimeco F., and Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64 (2004) 7011-7021
11. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., and De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 445 (2007) 111-115
12. Schatton T., Murphy G.F., Frank N.Y., Yamaura K., Waaga-Gasser A.M., Gasser M., Zhan Q., Jordan S., Duncan L.M., Weishaupt C., Fuhlbrigge R.C., Kupper T.S., Sayegh M.H., and Frank M.H. Identification of cells initiating human melanomas. Nature 451 (2008) 345-349
13. Kondo T. Brain cancer stem-like cells. Eur. J. Cancer 42 (2006) 1237-1242
14. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., and Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444 (2006) 756-760
15. Dean M., Fojo T., and Bates S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 5 (2005) 275-284
16. Ignatova T.N., Kukekov V.G., Laywell E.D., Suslov O.N., Vrionis F.D., and Steindler D.A. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39 (2002) 193-206
17. Yuan X., Curtin J., Xiong Y., Liu G., Waschsmann-Hogiu S., Farkas D.L., Black K.L., and Yu J.S. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23 (2004) 9392-9400
18. Lee J., Kotliarova S., Kotliarov Y., Li A., Su Q., Donin N.M., Pastorino S., Purow B.W., Christopher N., Zhang W., Park J.K., and Fine H.A. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9 (2006) 391-403
19. Lee J., Son M.J., Woolard K., Donin N.M., Li A., Cheng C.H., Kotliarova S., Kotliarov Y., Walling J., Ahn S., Kim M., Totonchy M., Cusack T., Ene C., Ma H., Su Q., Zenklusen J.C., Zhang W., Maric D., and Fine H.A. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 13 (2008) 69-80
20. Piccirillo S.G., Reynolds B.A., Zanetti N., Lamorte G., Binda E., Broggi G., Brem H., Olivi A., Dimeco F., and Vescovi A.L. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444 (2006) 761-765
21. Beier D., Hau P., Proescholdt M., Lohmeier A., Wischhusen J., Oefner P.J., Aigner L., Brawanski A., Bogdahn U., and Beier C.P. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 67 (2007) 4010-4015
22. Calabrese C., Poppleton H., Kocak M., Hogg T.L., Fuller C., Hamner B., Oh E.Y., Gaber M.W., Finklestein D., Allen M., Frank A., Bayazitov I.T., Zakharenko S.S., Gajjar A., Davidoff A., and Gilbertson R.J. A perivascular niche for brain tumor stem cells. Cancer Cell 11 (2007) 69-82
23. Kondo T., Setoguchi T., and Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc. Natl. Acad. Sci. USA 101 (2004) 781-786
24. Bleau A.M., Hambardzumyan D., Ozawa T., Fomchenko E.I., Huse J.T., Brennan C.W., and Holland E.C. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Stem Cells 4 (2009) 226-235
25. Harris M.A., Yang H., Low B.E., Mukherje J., Guha A., Bronson R.T., Shultz L.D., Israel M.A., and Yun K. Cancer stem cells are enriched in the side population cells in a mouse model of glioma. Cancer Res. 68 (2008) 10051-10059
26. Scharenberg C.W., Harkey M.A., and Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99 (2002) 507-512
27. Goodell M.A., Brose K., Paradis G., Conner A.S., and Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183 (1996) 1797-1806
28. Diestra J.E., Scheffer G.L., Catala I., Maliepaard M., Schellens J.H., Scheper R.J., Germa-Lluch J.R., and Izquierdo M.A. Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material. J. Pathol. 198 (2002) 213-219
29. Chen C.J., Chin J.E., Ueda K., Clark D.P., Pastan I., Gottesman M.M., and Roninson I.B. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47 (1986) 381-389
30. Cole S.P., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M., and Deeley R.G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258 (1992) 1650-1654
31. Doyle L.A., Yang W., Abruzzo L.V., Krogmann T., Gao Y., Rishi A.K., and Ross D.D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA 95 (1998) 15665-15670
32. Bunting K.D. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 20 (2002) 11-20
33. Kim M., Turnquist H., Jackson J., Sgagias M., Yan Y., Gong M., Dean M., Sharp J.G., and Cowan K. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin. Cancer Res. 8 (2002) 22-28
34. Lobo M.V., Arenas M.I., Alonso F.J., Gomez G., Bazan E., Paino C.L., Fernandez E., Fraile B., Paniagua R., Moyano A., and Caso E. Nestin, a neuroectodermal stem cell marker molecule is expressed in Leydig cells of the human testis and in some specific cell types from human testicular tumours. Cell Tissue Res. 316 (2004) 369-376
35. Yoon K., and Gaiano N. Notch signaling in the mammalian central nervous system: insights from mouse mutants. Nat. Neurosci. 8 (2005) 709-715
36. Gaiano N., and Fishell G. The role of notch in promoting glial and neural stem cell fates. Annu. Rev. Neurosci. 25 (2002) 471-490
37. Koch U., and Radtke F. Notch and cancer: a double-edged sword. Cell Mol. Life Sci. 64 (2007) 2746-2762
38. Patrawala L., Calhoun T., Schneider-Broussard R., Zhou J., Claypool K., and Tang D.G. Side population is enriched in tumorigenic, stem-like cancer cells whereas, ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res. 65 (2005) 6207-6219
39. Bar E.E., Chaudhry A., Lin A., Fan X., Schreck K., Matsui W., Vescovi A.L., Piccirillo S., Dimeco F., Olivi A., and Eberhart C.G. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells (2007)
40. Fan X., Matsui W., Khaki L., Stearns D., Chun J., Li Y.M., and Eberhart C.G. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res. 66 (2006) 7445-7452
41. Yu S.C., Ping Y.F., Yi L., Zhou Z.H., Chen J.H., Yao X.H., Gao L., Wang J.M., and Bian X.W. Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett. 265 (2008) 124-134
42. Qiang L., Yang Y., Ma Y.J., Chen F.H., Zhang L.B., Liu W., Qi Q., Lu N., Tao L., Wang X.T., You Q.D., and Guo Q.L. Isolation and characterization of cancer stem like cells in human glioblastoma cell lines. Cancer Lett. 279 (2009) 13-21
43. Zheng X., Shen G., Yang X., and Liu W. Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res. 67 (2007) 3691-3697
44. Dirks P.B. Brain tumour stem cells: the undercurrents of human brain cancer and their relationship to neural stem cells. Philos. Trans. Roy. Soc. Lond. B Biol. Sci. 363 (2008) 139-152
45. Vescovi A.L., Galli R., and Reynolds B.A. Brain tumour stem cells. Nat. Rev. Cancer 6 (2006) 425-436
46. Bhattacharya S., Das A., Mallya K., and Ahmad I. Maintenance of retinal stem cells by Abcg2 is regulated by notch signaling. J. Cell Sci. 120 (2007) 2652-2662
47. Shih A.H., and Holland E.C. Notch signaling enhances Nestin expression in gliomas. Neoplasia 8 (2006) 1072-1082
48. Solecki D.J., Liu X.L., Tomoda T., Fang Y., and Hatten M.E. Activated Notch2 signaling inhibits differentiation of cerebellar granule neuron precursors by maintaining proliferation. Neuron 31 (2001) 557-568
49. Radtke F., and Raj K. The role of notch in tumorigenesis: oncogene or tumour suppressor?. Nat. Rev. Cancer 3 (2003) 756-767
50. Weng A.P., and Aster J.C. Multiple niches for Notch in cancer: context is everything. Curr. Opin. Genet. Dev. 14 (2004) 48-54